Update in Mantle Cell Lymphoma
Nikesh Shah, MD, and Eduardo Sotomayor, MD, describe the implications of TP53 alterations in MCL, analyze the current treatment options for MCL, review recent updates in treatment for MCL - including novel therapies such as bispecific antibodies and targeted agents.
Published
October 16, 2023
Expires
October 16, 2024
Presenters
Director, TGH Cancer Institute Professor, Department of Medical Engineering, College of Engineering, USF
Hematologist/Oncologist